Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer

Table 6

Summary of top pathways returned by KEGG using DAVID for early- and late-stage cancer.

Early-stage NSCLC
Term	Count	%	value
Leukocyte transendothelial migration	4	18.2	0.00294
Glycolysis/gluconeogenesis	3	13.6	0.00982
Epithelial cell signaling in Helicobacter pylori infection	3	13.6	0.0125
Cell adhesion molecules (CAMs)	3	13.6	0.0432
Tight junction	3	13.6	0.0444
Focal adhesion	3	13.6	0.0911
Late-stage NSCLC
Term	Count	%	value
Cell cycle	12	19.7
Oocyte meiosis	8	13.1
Progesterone-mediated oocyte maturation	6	9.8
DNA replication	3	4.9	0.0250
p53 signaling pathway	3	4.9	0.0791